TriplePoint Venture Growth BDC - TPVG Stock Price Target and Predictions

  • Consensus Rating: Reduce
  • Consensus Price Target: $10.38
  • Forecasted Upside: 13.51%
  • Number of Analysts: 5
  • Breakdown:
  • 1 Sell Ratings
  • 4 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$9.14
▲ +0.1 (1.11%)

This chart shows the closing price for TPVG by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New TriplePoint Venture Growth BDC Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TPVG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TPVG

Analyst Price Target is $10.38
▲ +13.51% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for TriplePoint Venture Growth BDC in the last 3 months. The average price target is $10.38, with a high forecast of $13.50 and a low forecast of $8.75. The average price target represents a 13.51% upside from the last price of $9.14.

This chart shows the closing price for TPVG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Reduce

The current consensus among 5 contributing investment analysts is to reduce stock in TriplePoint Venture Growth BDC. This Reduce consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 1 sell ratings
10/26/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 1 sell ratings
1/24/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 1 sell ratings
4/24/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 1 sell ratings
7/23/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 1 sell ratings
10/21/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 1 sell ratings
1/19/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 1 sell ratings
3/19/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 1 sell ratings
4/18/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/22/2024Compass PointUpgradeSell ➝ Neutral$8.75Low
3/7/2024Keefe, Bruyette & WoodsLower TargetUnderperform ➝ Underperform$9.50 ➝ $9.00Low
3/7/2024Compass PointDowngradeNeutral ➝ Sell$8.75Low
3/7/2024JMP SecuritiesReiterated RatingOutperform ➝ Market PerformLow
3/7/2024Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$11.00 ➝ $9.50Low
3/7/2024Piper SandlerLower TargetNeutral ➝ Neutral$11.00 ➝ $10.00N/A
12/20/2023Piper SandlerBoost TargetNeutral ➝ Neutral$10.00 ➝ $11.00Low
11/2/2023Piper SandlerLower TargetNeutral ➝ Neutral$11.00 ➝ $10.00N/A
10/5/2023Piper SandlerLower TargetNeutral ➝ Neutral$12.00 ➝ $11.00Low
8/23/2023Compass PointUpgradeSell ➝ Neutral$9.75Low
8/21/2023JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$11.50Low
8/3/2023Compass PointDowngradeNeutral ➝ Sell$9.75Low
5/23/2023JMP SecuritiesLower Target$13.50 ➝ $11.50Low
5/4/202322nd Century GroupReiterated RatingDowngradeLow
5/4/2023LADENBURG THALM/SH SHLower Target$14.50 ➝ $13.50Low
5/4/2023Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$12.00 ➝ $10.00Low
3/13/2023JMP SecuritiesReiterated RatingMarket Outperform$13.50Low
3/3/2023JMP SecuritiesLower TargetMarket Outperform$15.00 ➝ $13.50Low
12/20/2022Keefe, Bruyette & WoodsDowngradeMarket Perform ➝ Underperform$13.00 ➝ $10.00Low
12/16/2022Piper SandlerLower Target$13.50 ➝ $12.00Low
12/13/2022Piper SandlerDowngradeOverweight ➝ Neutral$14.50 ➝ $13.50Low
12/1/2022UBS GroupInitiated CoverageNeutral$13.50Low
11/9/2022JMP SecuritiesLower TargetMarket Outperform$16.00 ➝ $15.00Low
10/24/2022Wells Fargo & CompanyLower TargetOverweight$14.50 ➝ $13.50Low
10/3/2022Piper SandlerLower TargetOverweight$16.00 ➝ $14.50Low
6/28/2022Piper SandlerLower TargetOverweight$19.00 ➝ $16.00Low
4/25/2022Wells Fargo & CompanyBoost TargetOverweight$17.50 ➝ $18.00Low
11/5/2021JMP SecuritiesBoost TargetMarket Outperform$16.50 ➝ $19.00High
10/15/2021Compass PointDowngradeBuy ➝ Neutral$15.75High
9/21/2021Compass PointUpgradeNeutral ➝ Buy$15.50 ➝ $16.50Medium
8/6/2021JMP SecuritiesBoost TargetMarket Outperform$16.00 ➝ $16.50Low
7/12/2021Piper SandlerInitiated CoverageOverweight$17.00High
5/19/2021OppenheimerInitiated CoverageMarket PerformLow
11/19/2020JMP SecuritiesInitiated CoverageOutperform$13.00Medium
8/6/2020Wells Fargo & CompanyBoost TargetOverweight$11.25 ➝ $11.75Low
8/6/2020LADENBURG THALM/SH SHBoost TargetBuy$9.00 ➝ $12.00Medium
5/13/2020Compass PointDowngradeBuy ➝ Neutral$8.00 ➝ $8.50High
5/8/2020Deutsche Bank AktiengesellschaftLower TargetBuy$15.50 ➝ $11.50High
5/7/2020Keefe, Bruyette & WoodsBoost TargetMarket Perform$8.00 ➝ $9.00Low
4/27/2020Wells Fargo & CompanyBoost TargetOverweight$9.00 ➝ $9.25High
4/2/2020Compass PointUpgradeNeutral ➝ Buy$8.00Low
3/25/2020Wells Fargo & CompanyLower TargetOverweight$13.75 ➝ $9.00Low
3/5/2020Wells Fargo & CompanyLower TargetOverweight$14.50 ➝ $13.75Medium
3/5/2020LADENBURG THALM/SH SHUpgradeNeutral ➝ Buy$13.50Medium
1/14/2020JMP SecuritiesInitiated CoverageOutperform$15.50Low
9/19/2019Wells Fargo & CompanyBoost TargetOutperform$15.00 ➝ $16.00Low
7/8/2019Nomura SecuritiesInitiated CoverageBuy ➝ Buy$16.00Medium
5/6/2019Compass PointDowngradeBuy ➝ Neutral$14.50Low
(Data available from 4/19/2019 forward)

News Sentiment Rating

0.95 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
9/22/2023
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/22/2023
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
11/21/2023
  • 2 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/21/2023
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/20/2024
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/19/2024
  • 10 very positive mentions
  • 13 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
3/20/2024
  • 6 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/19/2024

Current Sentiment

  • 6 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
TriplePoint Venture Growth BDC logo
TriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments. It also provides debt financing to venture growth space companies which includes growth capital loans, secured and customized loans, equipment financings, revolving loans and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It targeted returns between 10% and 18%. It does not take board seat in the company.
Read More

Today's Range

Now: $9.14
Low: $9.06
High: $9.17

50 Day Range

MA: $9.88
Low: $8.96
High: $11.02

52 Week Range

Now: $9.14
Low: $8.88
High: $12.70

Volume

145,743 shs

Average Volume

286,934 shs

Market Capitalization

$343.85 million

P/E Ratio

N/A

Dividend Yield

17.78%

Beta

1.77

Frequently Asked Questions

What sell-side analysts currently cover shares of TriplePoint Venture Growth BDC?

The following Wall Street sell-side analysts have issued reports on TriplePoint Venture Growth BDC in the last twelve months: 22nd Century Group, Inc., Compass Point, JMP Securities, Keefe, Bruyette & Woods, LADENBURG THALM/SH SH, Piper Sandler, StockNews.com, and Wells Fargo & Company.
View the latest analyst ratings for TPVG.

What is the current price target for TriplePoint Venture Growth BDC?

6 Wall Street analysts have set twelve-month price targets for TriplePoint Venture Growth BDC in the last year. Their average twelve-month price target is $10.38, suggesting a possible upside of 13.5%. LADENBURG THALM/SH SH has the highest price target set, predicting TPVG will reach $13.50 in the next twelve months. Compass Point has the lowest price target set, forecasting a price of $8.75 for TriplePoint Venture Growth BDC in the next year.
View the latest price targets for TPVG.

What is the current consensus analyst rating for TriplePoint Venture Growth BDC?

TriplePoint Venture Growth BDC currently has 1 sell rating and 4 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Reduce."
View the latest ratings for TPVG.

What other companies compete with TriplePoint Venture Growth BDC?

How do I contact TriplePoint Venture Growth BDC's investor relations team?

TriplePoint Venture Growth BDC's physical mailing address is 2755 SAND HILL ROAD SUITE 150, MENLO PARK CA, 94025. The investment management company's listed phone number is (650) 854-2090 and its investor relations email address is [email protected]. The official website for TriplePoint Venture Growth BDC is www.tpvg.com. Learn More about contacing TriplePoint Venture Growth BDC investor relations.